This is a firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The $10,217 maintenance agreement contract does not have a set-aside designation and will provide preventative maintenance, on-site performance assurance, and repair services for Molecular Devices' specialized bioanalytical instruments used in healthcare research, public health initiatives, and drug discovery programs supported by the National Cancer Institute. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, including microplate readers, high-content imaging systems, and electrophysiology equipment, which facilitate life sciences research and translational medicine across federal scientific programs.
Generated 3/23/25, 1:00 AM